What is the role of colchicine in the treatment of pericarditis?

Role of Colchicine in Pericarditis

Colchicine is a first-line medication that should be added to NSAIDs or aspirin for all patients with acute pericarditis and is essential for preventing recurrences, reducing the recurrence rate by approximately 50%. 1, 2

First-Line Therapy: Colchicine Plus NSAIDs/Aspirin

Colchicine must be prescribed alongside NSAIDs or aspirin as combination first-line therapy, not as monotherapy. 1, 2 The European Society of Cardiology establishes this as a Class I, Level A recommendation. 1

Dosing Protocol

• Weight-adjusted dosing: 0.5 mg once daily if body weight <70 kg, or 0.5 mg twice daily if ≥70 kg 1, 2
• No loading dose should be used for recurrent pericarditis 1
• Treatment duration: 3 months for first episode of acute pericarditis 2
• Extended duration (≥6 months) should be considered for recurrent pericarditis based on clinical response 1

Companion NSAID Therapy

• Aspirin 750-1000 mg every 8 hours OR ibuprofen 600 mg every 8 hours for 1-2 weeks 2
• Gastroprotection is mandatory 2
• Taper gradually after CRP normalization (aspirin by 250-500 mg every 1-2 weeks) 2

Evidence of Efficacy

The landmark COPE trial demonstrated that colchicine reduced recurrence rates from 32.3% to 10.7% (number needed to treat = 5) in patients with first episode of acute pericarditis. 3 This represents a clinically dramatic benefit that has been consistently replicated across multiple randomized trials.

• Meta-analysis data confirms colchicine reduces recurrent pericarditis incidence from 36.8% to 16.7% (RR 0.46,95% CI 0.36-0.58) 4
• Colchicine halves the recurrence rate after initial pericarditis episodes 1
• Without colchicine, recurrence rates increase to 50% after a first recurrence, particularly if corticosteroids were used 1

When Colchicine is Contraindicated

Colchicine is contraindicated in severe renal impairment (CrCl <30 mL/min). 2 In these cases:

• Dose reduction required: 0.3 mg once daily for CrCl <30 mL/min 2
• Dialysis patients: Maximum 0.3 mg twice weekly 2
• Alternative approach: Use high-dose NSAIDs alone, or low-dose corticosteroids (prednisone 0.2-0.5 mg/kg/day) if NSAIDs contraindicated, after excluding infectious causes 2, 5

Critical Pitfalls to Avoid

Corticosteroid use during the index attack is an independent risk factor for recurrences (OR 4.30,95% CI 1.21-15.25). 3 The ESC explicitly states corticosteroids are NOT recommended as first-line therapy (Class III, Level B recommendation). 1

• Inadequate treatment duration (less than 3 months of colchicine) substantially increases recurrence risk 2
• Premature tapering before CRP normalization and symptom resolution leads to recurrence 1, 2
• Using corticosteroids first-line promotes chronicity and increases recurrence rates despite providing rapid symptom control 1

Side Effects and Tolerability

• Gastrointestinal intolerance is the most common side effect, occurring in 12.5% vs 8.5% with placebo (RR 1.45) 4
• Drug withdrawal rate: 10.8% vs 8.5% with placebo, primarily due to diarrhea 4
• In the COPE trial, colchicine was discontinued in 8.3% of cases due to diarrhea, with no serious adverse effects observed 3

Special Clinical Scenarios

Post-Pericardiotomy Syndrome

• Colchicine reduces post-pericardiotomy syndrome incidence from 25.8% to 13.2% at 1 year (RR 0.56) 4
• Only use if systemic inflammation is documented; not indicated for asymptomatic post-surgical effusions 2

Isolated Pericardial Effusion Without Inflammation

• Colchicine is NOT indicated for isolated pericardial effusion with normal CRP and no evidence of systemic inflammation 2
• Anti-inflammatory drugs are ineffective in this setting 2

Uraemic Pericarditis

• Colchicine is contraindicated due to severe renal impairment 2
• Intensify dialysis as primary treatment 2

Monitoring and Duration

• CRP should guide treatment duration and assess response to therapy 1, 2
• Exercise restriction until symptom resolution and CRP, ECG, and echocardiogram normalization 1, 2
• Athletes require minimum 3 months of exercise restriction 1, 2
• Taper medications only when symptoms are absent and CRP is normal, stopping one drug class at a time 1